The DOI matches its Crossref record.
Hypoglycemia in the Diabetes Control and Complications Trial
Abstract
A total of 1,441 patients with IDDM were randomly assigned to receive either intensive (n = 711) or conventional (n = 730) diabetes therapy in the Diabetes Control and Complications Trial (DCCT). The patients were followed for an average of 6.5 years. Subjects were instructed to report all episodes of suspected severe hypoglycemia to their health care team. In addition, at quarterly follow-up visits, each subject was asked about the occurrence of severe hypoglycemia. There were 3,788 episodes of severe hypoglycemia (requiring assistance); 1,027 of these episodes were associated with coma and/or seizure. A total of 65% percent of patients in the intensive group vs. 35% of patients in the conventional group had at least one episode of severe hypoglycemia by the study end; the overall rates of severe hypoglycemia were 61.2 per 100 patient-years vs. 18.7 per 100 patient-years in the intensive and conventional treatment groups, respectively, with a relative risk (RR) of 3.28. The relative risk for coma and/or seizure was 3.02 for intensive therapy. The increased risk with intensive treatment persisted over each of the 9 years of follow-up in the DCCT and over the calendar years 1984–1993 during which the study was conducted. When baseline patient characteristics were examined for effects on the risk of severe hypoglycemia, the relative risk of hypoglycemia for intensive versus conventional treatment was ≥2 for all subgroups. Several subgroups defined by baseline characteristics, including males, adolescents, and subjects with no residual C-peptide or with a prior history of hypoglycemia, had a particularly high risk of severe hypoglycemia in both treatment groups. Analyses of the cumulative incidence of successive episodes indicated that intensive treatment was also associated with an increased risk of multiple episodes within the same patient (e.g., 22% experienced five or more episodes of severe hypoglycemia within the first 5 years of follow-up vs. 4% in the conventional group). Within both treatment groups, patients who experienced severe hypoglycemia were at increased risk of subsequent episodes. Approximately 30% of patients in each group experienced a second episode within the 4 months following the first episode of severe hypoglycemia. Within each treatment group, the number of prior episodes of hypoglycemia was the strongest predictor of the risk of future episodes, followed closely by the current HbA1c value. After adjustment for the current quarterly HbA1c level, intensive treatment was still associated with a significantly increased risk of hypoglycemia, indicating that the increased risk with intensive treatment is not completely explained by differences in HbA1c values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized controlled trials have established that intensive glycemic therapy prevents or delays the microvascular complications-retinopathy, nephropathy, and neuropathy-of diabetes (122, 123, 131, 144, 145), albeit at the expense of an increased frequency of hypoglycemia (117, 118, 122, 123, 132, 133, 144, 145).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [133]
In the citing paper
“A glucose of <70 mg/dL (3.9 mmol/L) is the classic threshold for hypoglycemia based on physiologic glucose regulation and neuroendocrine response in persons without DM.1197”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1197]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 779
Kovatchev, B. P., Cox, D. J., Kumar, A., Gonder-Frederick, L. A., & Clarke, W. L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322527021 · Cited by 157
Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study
Gubitosi‐Klug, R., Braffett, B. H., White, N. H., Sherwin, R. S., Service, F. J., Lachin, J. M., & Tamborlane, W. V. (2017) · Diabetes Care · doi:10.2337/dc16-2723 · Cited by 160
Tanenberg, R. J., Bode, B. W., Lane, W. S., Levetan, C. S., Mestman, J. H., Peters, A. L., Tobian, J. A., Gross, T. M., & Mastrototaro, J. J. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.12.1521 · Cited by 143
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Kedia (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s20633 · Cited by 150
Pedersen‐Bjergaard, U., Agerholm-Larsen, B., Pramming, S., Hougaard, P., & Thorsteinsson, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04405-6 · Cited by 129
Akram, K., Pedersen‐Bjergaard, U., Carstensen, B., Borch‐Johnsen, K., & Thorsteinsson, B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01880.x · Cited by 141
Prediction of Severe Hypoglycemia
Cox, D. J., Gonder-Frederick, L., Ritterband, L., Clarke, W., & Kovatchev, B. P. (2007) · Diabetes Care · doi:10.2337/dc06-1386 · Cited by 129
Cariou, B., Fontaine, P., Eschwege, E., Lièvre, M., Gouet, D., Huet, D., Madani, S., Lavigne, S., & Charbonnel, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.10.007 · Cited by 129
Spyer, G., Hattersley, A. T., MacDonald, I., Amiel, S., & MacLeod, K. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03322-5 · Cited by 126
A critical review of mathematical models and data used in diabetology
Boutayeb, A., & Chetouani, A. (2006) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-5-43 · Cited by 126
The Maillard Reaction in Eye Diseases
Stitt, A. W. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.066 · Cited by 143
Kovatchev, B. P., Straume, M., Cox, D. J., & Farhy, L. S. (2000) · Computational and Mathematical Methods in Medicine · doi:10.1080/10273660008833060 · Cited by 127
Correlation between extracellular glucose and seizure susceptibility in adult rats
Schwechter, E. M., Velíšková, J., & Velíšek, L. (2002) · Annals of Neurology · doi:10.1002/ana.10415 · Cited by 126
El-Khatib, F. H., Russell, S. J., Magyar, K. L., Sinha, M., McKeon, K., Nathan, D. M., & Damiano, E. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4151 · Cited by 129
Hypoglycemia and Cardiovascular Risk: Is There a Major Link?
Hanefeld, M., Frier, B. M., & Pistrosch, F. (2016) · Diabetes Care · doi:10.2337/dcs15-3014 · Cited by 124
The role of leptin in diabetes: metabolic effects
Meek, T. H., & Morton, G. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3898-3 · Cited by 132
Foster, E. D., Bridges, N. D., Feurer, I. D., Eggerman, T. L., Hunsicker, L. G., Alejandro, R., Begley, B., Cano, J., Carpentier, S., Hutchinson, J., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1779 · Cited by 133
Technical aspects of islet preparation and transplantation
Lakey, J. R. T., Burridge, P. W., & Shapiro, A. M. J. (2003) · Transplant International · doi:10.1111/j.1432-2277.2003.tb00361.x · Cited by 121
JDRF CGM Study Group (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0302 · Cited by 124
Rama Chandran, S., Tay, W. L., Lye, W. K., Lim, L. L., Ratnasingam, J., Tan, A. T. B., & S.L. Gardner, D. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0388 · Cited by 114
High residual C-peptide likely contributes to glycemic control in type 1 diabetes
Rickels, M. R., Evans‐Molina, C., Bahnson, H. T., Ylescupidez, A., Nadeau, K. J., Hao, W., Clements, M. A., Sherr, J. L., Pratley, R. E., Hannon, T. S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134057 · Cited by 128
Lobnig, B. M., Krömeke, O., Optenhostert‐Porst, C., & Wolf, O. T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01716.x · Cited by 125
Gale, E. A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00258.x · Cited by 112
Glycemic Variability: Risk Factors, Assessment, and Control
Kovatchev, B. P. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819826111 · Cited by 124
Turgeon, N. A., Ávila, J. G., Cano, J. A., Hutchinson, J., Badell, I. R., Page, A. J., Adams, A. B., Sears, M. H., Bowen, P. H., Kirk, A. D., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03212.x · Cited by 108
Plank, J., K�hler, G., Rakovac, I., Semlitsch, B., Horvath, K., Bock, G., Kraly, B., & Pieber, T. R. (2004) · Diabetologia · doi:10.1007/s00125-004-1456-x · Cited by 108
Are Individuals With Diabetes Seeing Better?
Klein, R., & Klein, R. (2010) · Diabetes · doi:10.2337/db09-1904 · Cited by 109
Yale, J.-F., Paty, B., & Senior, P. A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.010 · Cited by 105
Hermanns, N., Kulzer, B., Ehrmann, D., Bergis-Jurgan, N., & Haak, T. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.009 · Cited by 105
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
Jarosinski, M. A., Dhayalan, B., Rege, N. K., Chatterjee, D., & Weiss, M. A. (2021) · Diabetologia · doi:10.1007/s00125-021-05422-6 · Cited by 110
Puente, E. C., Silverstein, J., Bree, A. J., Musikantow, D. R., Wozniak, D. F., Maloney, S., Daphna-Iken, D., & Fisher, S. J. (2010) · Diabetes · doi:10.2337/db09-1495 · Cited by 103
Current Advances in the Management of Diabetes Mellitus
Aloke, C., Egwu, C. O., Aja, P. M., Obasi, N. A., Chukwu, J. A., Akumadu, B. O., Ogbu, P. N., & Achilonu, I. (2022) · Biomedicines · doi:10.3390/biomedicines10102436 · Cited by 157
Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen
Heller, S. R., Peyrot, M. F., Oates, S. K., & Taylor, A. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001194 · Cited by 111
Diabetes mellitus: Relevance to dental treatment
Vernillo, A. (2001) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1067/moe.2001.114002 · Cited by 125
Hypoglycaemia during pregnancy in women with Type 1 diabetes
Ringholm, L., Pedersen‐Bjergaard, U., Thorsteinsson, B., Damm, P., & Mathiesen, E. R. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03604.x · Cited by 101
Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus
Schultes, B., Jauch-Chara, K., Gais, S., Hallschmid, M., Reiprich, E., Kern, W., Oltmanns, K. M., Peters, A., Fehm, H. L., & Born, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040069 · Cited by 100
Abraham, M. B., Karges, B., Dovč, K., Naranjo, D. M., Arbeláez, A. M., Mbogo, J., Javelikar, G., Jones, T. W., & Mahmud, F. H. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13443 · Cited by 134
Serious Cardiovascular Outcomes in Diabetes: The Role of Hypoglycemia
Yakubovich, N., & Gerstein, H. C. (2011) · Circulation · doi:10.1161/circulationaha.110.948489 · Cited by 111
HYPOS-1 Study Group of AMD, Giorda, C. B., Ozzello, A., Gentile, S., Aglialoro, A., Chiambretti, A., Baccetti, F., Gentile, F. M., Lucisano, G., Nicolucci, A., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0713-4 · Cited by 97
Prospective and Challenges of Islet Transplantation for the Therapy of Autoimmune Diabetes
Balamurugan, A. N., Bottino, R., Giannoukakis, N., & Smetanka, C. (2006) · Pancreas · doi:10.1097/01.mpa.0000203961.16630.2f · Cited by 108
Duloxetine for Patients with Diabetic Peripheral Neuropathic Pain: A 6-Month Open-Label Safety Study
Raskin, J., Wang, F., Pritchett, Y., & GOLDSTEIN, D. J. (2006) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00207.x · Cited by 105
Garg, S. K., Moser, E. G., Bode, B. W., Klaff, L. J., Hiatt, W. R., Beatson, C. R., & Snell‐Bergeon, J. K. (2012) · Endocrine Practice · doi:10.4158/ep12100.or · Cited by 101
Breton, M. D., Patek, S. D., Lv, D., Schertz, E. M., Robic, J., Pinnata, J., Kollar, L. L., Barnett, C. L., WAKEMAN, C. A., Oliveri, M. C., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0079 · Cited by 103
Physiologic insulin delivery with insulin feedback: A control systems perspective
Palerm, C. C. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.06.007 · Cited by 104
Wang, C., Lv, L., Yang, Y., Chen, D., Liu, G., Chen, L., Song, Y., He, L., Li, X., Tian, H., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04205.x · Cited by 112
Standl, E., Lang, H., & Roberts, A. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.579 · Cited by 99
Yang, W., Chen, L., Ji, Q., Liu, X., Ma, J., Tandon, N., Bhattacharyya, A., Kumar, A., Kim, K.-W., Yoon, K., et al. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01323.x · Cited by 97
Engineering Glucose Responsiveness Into Insulin
Kaarsholm, N. C., Lin, S., Yan, L. Y., Kelly, T. M., van Heek, M., Mu, J., Wu, M. S., Dai, G., Cui, Y., Zhu, Y., et al. (2017) · Diabetes · doi:10.2337/db17-0577 · Cited by 93
Cobden, D., Lee, W. C., Balu, S., Joshi, A. V., & Pashos, C. L. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.948 · Cited by 91
Advances in pancreatic islet transplantation in humans
Nanji, S. A., & Shapiro, A. M. J. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00476.x · Cited by 93
Cox, D. J., Kovatchev, B., Kovatchev, B., Koev, D., Koeva, L., Dachev, S., Tcharaktchiev, D., Protopopova, A., Gonder-Frederick, L., & Clarke, W. (2004) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1104_4 · Cited by 88
Haynes, A., Hermann, J. M., Miller, K. M., Hofer, S. E., Jones, T. W., Beck, R. W., Maahs, D. M., Davis, E. A., Holl, R. W., & for the T1D Exchange, W. A. D. R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12477 · Cited by 88
O'Grady, M. J., Retterath, A. J., Keenan, D. B., Kurtz, N., Cantwell, M., Spital, G., Kremliovsky, M. N., Roy, A., Davis, E. A., Jones, T. W., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0761 · Cited by 97
Effect of Acute and Recurrent Hypoglycemia on Changes in Brain Glycogen Concentration
Herzog, R. I., Chan, O. T. M., Yu, S., Dziura, J. D., McNay, E. C., & Sherwin, R. S. (2008) · Endocrinology · doi:10.1210/en.2007-1252 · Cited by 87
Influence of VMH fuel sensing on hypoglycemic responses
Chan, O. T. M., & Sherwin, R. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.08.005 · Cited by 93
Susceptibility of Interstitial Continuous Glucose Monitor Performance to Sleeping Position
Mensh, B. D., Wisniewski, N. A., Neil, B. M., & Burnett, D. R. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700408 · Cited by 97
Silva, I. B. B., Kimura, C. H., Colantoni, V. P., & Sogayar, M. C. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02977-y · Cited by 106
Lüddeke, H. ‐., Sreenan, S., Aczél, S., Maxeiner, S., Yenigün, M., Kozlovski, P., Gydesen, H., Dornhorst, A., & PREDICTIVE Study Group (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00677.x · Cited by 92
Schütt, M., Fach, E.-M., Seufert, J., Kerner, W., Lang, W., Zeyfang, A., Welp, R., Holl, R. W., & for the DPV Initiative and the German BMBF Competence Network Diabetes Mellitus (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03681.x · Cited by 90
Evolution of Islet Transplantation for the Last 30 Years
Farney, A. C., Sutherland, D. E. R., & Opara, E. C. (2015) · Pancreas · doi:10.1097/mpa.0000000000000391 · Cited by 99
Dornhorst, A., Lüddeke, H. ‐., Sreenan, S., Koenen, C., Hansen, J. B., Tsur, A., Landstedt‐Hallin, L., & on behalf of the PREDICTIVE Study Group (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01316.x · Cited by 89
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L. A., & Clarke, W. L. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502760098438 · Cited by 85
Tight glycaemic control by an automated algorithm with time-variant sampling in medical icu patients
Pachler, C., Plank, J., Weinhandl, H., Chassin, L. J., Wilinska, M. E., Kulnik, R., Kaufmann, P., Smolle, K.-H., Pilger, E., Pieber, T. R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1033-8 · Cited by 82
Lin, Y. K., Fisher, S. J., & Pop‐Busui, R. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13290 · Cited by 82
McSorley, P., Bell, P. M., Jacobsen, L. V., Kristensen, A., & Lindholm, A. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85129-3 · Cited by 82
Lin, Y. K., Hung, M., Sharma, A. R., Chan, O. T. M., Varner, M. W., Staskus, G., & Fisher, S. J. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0527 · Cited by 92
Evaluation of Two Synthetic Glucose Probes for Fluorescence-Lifetime-Based Sensing
DiCésare, N., & Lakowicz, J. R. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5170 · Cited by 81
Hermanns, N., Kulzer, B., Kubiak, T., Krichbaum, M., & Haak, T. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.710 · Cited by 82
Automated closed-loop control of diabetes: the artificial pancreas
Kovatchev, B. P. (2018) · Bioelectronic Medicine · doi:10.1186/s42234-018-0015-6 · Cited by 90
Badugu, R., Lakowicz, J. R., & Geddes, C. D. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.058 · Cited by 80
A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
Kovatchev, B. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.04.008 · Cited by 80
SGLT inhibitor adjunct therapy in type 1 diabetes
McCrimmon, R. J., & Henry, R. R. (2018) · Diabetologia · doi:10.1007/s00125-018-4671-6 · Cited by 79
Wavelength-ratiometric probes for saccharides based on donor–acceptor diphenylpolyenes
DiCésare, N., & Lakowicz, J. R. (2001) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/s1010-6030(01)00471-3 · Cited by 78
Hussain, S. A. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.089 · Cited by 77
de Champdoré, M., Staiano, M., Rossi, M., & D’Auria, S. (2006) · Journal of The Royal Society Interface · doi:10.1098/rsif.2006.0174 · Cited by 77
Fulcher, G. R., Gilbert, R. E., & Yue, D. K. (2005) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2005.00902.x · Cited by 78
Prediction and prevention of hypoglycaemic events in type-1 diabetic patients using machine learning
Vehí, J., Contreras, I., Oviedo, S., Biagi, L., & Bertachi, A. (2020) · Health Informatics Journal · doi:10.1177/1460458219850682 · Cited by 76
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes
Gruden, G., Barutta, F., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D. A., Witte, D. R., Fuller, J., Perin, P. C., & Bruno, G. (2012) · Diabetes Care · doi:10.2337/dc11-1531 · Cited by 84
Realising the long-term promise of insulin therapy: the DCCT/EDIC study
Nathan, D. M. (2021) · Diabetologia · doi:10.1007/s00125-021-05397-4 · Cited by 91
Kovatchev, B. P., Cox, D. J., Farhy, L. S., Straume, M., Gonder-Frederick, L. A., & Clarke, W. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6999 · Cited by 78
Haemoglobin A 1c in the diagnosis and monitoring of diabetes mellitus
Kilpatrick, E. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.054304 · Cited by 79
Glycated haemoglobin in the year 2000
Kilpatrick, E. S. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.5.335 · Cited by 76
Jansà, M., Quirós, C., Giménez, M., Vidal, M., Galindo, M., & Conget, I. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2013.11.036 · Cited by 81
Davis, S. N., Mann, S., Briscoe, V. J., Ertl, A. C., & Tate, D. B. (2009) · Diabetes · doi:10.2337/db08-1230 · Cited by 74
Andersen, M. L. M., Hougaard, P., Pörksen, S., Nielsen, L. B., Fredheim, S., Svensson, J., Thomsen, J. F., Vikre-Jørgensen, J., Hertel, T., Petersen, J. S., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12208 · Cited by 83
New insulins in the treatment of diabetes mellitus
Lindholm, A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0321 · Cited by 79
Edelman, S. V., & Weyer, C. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/15209150260007390 · Cited by 78
Riemsma, R., Ramos, I. C., Birnie, R., Büyükkaramikli, N., Armstrong, N., Ryder, S., Duffy, S., Worthy, G., Al, M., Severens, J. L., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20170 · Cited by 82
Bolo, N. R., Musen, G., Jacobson, A. M., Weinger, K., McCartney, R. L., Flores, V., Renshaw, P. F., & Simonson, D. C. (2011) · Diabetes · doi:10.2337/db11-0506 · Cited by 72
Point: Steady Progress and Current Challenges in Clinical Islet Transplantation
Mineo, D., Pileggi, A., Alejandro, R., & Ricordi, C. (2009) · Diabetes Care · doi:10.2337/dc09-0490 · Cited by 79
A Novel Analytical Method for Assessing Glucose Variability: Using CGMS in Type 1 Diabetes Mellitus
McCall, A. L., Cox, D. J., Crean, J., Gloster, M., & Kovatchev, B. P. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.644 · Cited by 74
Development of glucose-responsive ‘smart’ insulin systems
Rege, N. K., Phillips, N. F. B., & Weiss, M. A. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000345 · Cited by 83
Update in the CNS Response to Hypoglycemia
McCrimmon, R. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1927 · Cited by 72
Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems
Anhalt, H., & Bohannon, N. J. V. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0016 · Cited by 79
Diabetic retinopathy: Some cellular, molecular and therapeutic considerations
ARCHER, D. B. (1999) · Eye · doi:10.1038/eye.1999.130 · Cited by 76
Monami, M., Dicembrini, I., Kundisova, L., Zannoni, S., Nreu, B., & Mannucci, E. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12287 · Cited by 74
Aschner, P. J., Horton, E., Leiter, L. A., Munro, N. M., Skyler, J. S., & Management*, O. B. O. T. G. P. F. E. D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02296.x · Cited by 76
Automatic regulatory control in type 1 diabetes without carbohydrate counting
Colmegna, P. H., Garelli, F., Battista, H. D., & Sánchez‐Peña, R. (2018) · Control Engineering Practice · doi:10.1016/j.conengprac.2018.02.003 · Cited by 77
Parsaik, A. K., Murad, M. H., Sathananthan, A., Moorthy, V., Erwin, P. J., Chari, S. T., Carter, R. E., Farnell, M. B., Vege, S. S., Sarr, M. G., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03860.x · Cited by 68
Hypoglycemia in children with type 1 diabetes: current issues and controversies
Jones, T. W., & Davis, E. A. (2003) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2003.00025.x · Cited by 79
Metadata
- Authors
- The Diabetes Control and Complications Trial Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The Diabetes Control and Complications Trial Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-02-01
- Volume
- 46
- Issue
- 2
- Pages
- 271-286
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W4252271922
- Semantic Scholar
- 0b14f6e58470afda31b2a9daa1c3fb61be7dad5a
- Cited by
- 746
- References
- 0
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 30 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 36 · 2015: 47 · 2014: 45 · 2013: 36 · 2012: 33
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, type 1 diabetes, intensive insulin therapy, baseline characteristics, Diabetes Control and Complications Trial, hypoglycemia risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.